Yazarlar (12) |
![]() Türkiye |
![]() Türkiye |
![]() Türkiye |
![]() Türkiye |
![]() Türkiye |
![]() Türkiye |
![]() Kafkas Üniversitesi, Türkiye |
![]() Türkiye |
![]() Türkiye |
![]() Türkiye |
![]() Türkiye |
![]() Türkiye |
Özet |
Advanced colorectal cancer (CRC) remains a critical health care challenge worldwide. Various TGF-β superfamily members are important in colorectal cancer metastasis, but their signaling effects and predictive value have only been assessed in isolation. Here, we examine cross-regulation and combined functions of the two most prominent TGF-β superfamily members activin and TGF-β in advanced colorectal cancer. In two clinical cohorts we observed by immune-based assay that combined serum and tissue activin and TGF-β ligand levels predicts outcome in CRC patients and is superior to single ligand assessment. While TGF-β growth suppression is independent of activin, TGF-β treatment leads to increased activin secretion in colon cancer cells and TGF-β induced cellular migration is dependent on activin, indicating pathway cross-regulation and functional interaction in vitro. mRNA expression of activin and TGF-β pathway members were queried in silico using the TCGA data set. Coordinated ligand and receptor expression is common in solid tumors for activin and TGF-β pathway members. In conclusion, activin and TGF-β are strongly connected signaling pathways that are important in advanced CRC. Assessing activin and TGF-β signaling as a unit yields important insights applicable to future diagnostic and therapeutic interventions. |
Anahtar Kelimeler |
Makale Türü | Özgün Makale |
Makale Alt Türü | SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale |
Dergi Adı | SCIENTIFIC REPORTS |
Dergi ISSN | 2045-2322 Wos Dergi Scopus Dergi |
Dergi Tarandığı Indeksler | SCI |
Makale Dili | İngilizce |
Basım Tarihi | 07-2017 |
Cilt No | 7 |
Sayı | 1 |
Doi Numarası | 10.1038/s41598-017-05907-8 |
Makale Linki | http://www.nature.com/articles/s41598-017-05907-8 |